Allen Jeremias, MD, MSc is the Director of Interventional Cardiology Research and Associate Director of the Cardiac Catheterization Laboratory at St. Francis Hospital in Roslyn, New York. He is also a member of the Cardiovascular Research Foundation in New York City, where he currently serves as the Director of the Physiology Core Laboratory. He completed his medical training at The Cleveland Clinic Foundation, Stanford University School of Medicine, and Harvard Medical School. He has been a high-volume interventional cardiologist since 2006 and recognized as a Top Doctor in the New York Metro Area by Castle Connolly. Dr. Jeremias has significantly contributed to advancing the field of interventional cardiology and is considered one of the foremost authorities in coronary physiology and intravascular imaging. He is the author of more than 100 scientific articles, book chapters, and books on various aspects of intravascular imaging and coronary physiology. He has extensive experience leading core lab analyses for major international clinical trials, ensuring rigorous interpretation of imaging and physiologic data to refine interventional strategies and improve patient outcomes.

Dr. Evan Shlofmitz is an Interventional Cardiologist and the Director of Intravascular Imaging at St. Francis Hospital - The Heart Center in Roslyn, NY. He completed a fellowship in Interventional Cardiology at Georgetown University/MedStar Washington Hospital Center. He previously completed an Intravascular Imaging and Physiology fellowship at the Cardiovascular Research Foundation (CRF) and Columbia University Medical Center (CUMC), a Cardiovascular Disease fellowship at Northwell Health, and served as Chief Resident for Internal Medicine at New York-Presbyterian Queens. He serves on the steering committee for the pivotal IVUS trial, IMPROVE, and SCAI's Ischemic Heart Disease Council. Dr. Shlofmitz's research interests have centered on intravascular imaging and physiology, calcified coronary artery disease, and PCI optimization, with more than 100 publications in peer-reviewed journals. His deep involvement in core lab research has played a crucial role in validating imaging modalities for clinical decision-making and procedural guidance, directly influencing the evolution of contemporary interventional practices.

Omar Khalique, MD, FACC, FASE, FSCCT, FSCMR, FSCAI is the Director of the Division of Cardiovascular Imaging at Saint Francis Hospital and Catholic Health, Director of Cardiovascular Imaging Research at the Dematteis Institute, and Director of the Advanced Cardiovascular Imaging Fellowship. Saint Francis Hospital is one of a handful of institutions in the country where all cardiovascular imaging modalities (Cardiac CT, Cardiac MRI, Echocardiography, Nuclear SPECT/PET) are unified under a single division to form a comprehensive program. Dr. Khalique was previously with Columbia University Medical Center/New York-Presbyterian Hospital, where he was an Associate Professor of Medicine (in Radiology) and served as the Director of Multimodality Cardiac Imaging at the Structural Heart and Valve Center. Dr. Khalique was one of the world’s first multimodality cardiovascular imaging specialists and is a recognized expert and thought leader in the fields of multimodality cardiovascular imaging and structural heart imaging. He has published over 100 peer-reviewed manuscripts. He has served on the Journal of the American College of Cardiology’s (JACC) Cardiovascular Imaging expert panel on Imaging in Valvular Heart Disease and the American College of Cardiology’s Structural Heart Disease working group. Dr. Khalique serves on several important national research trial committees, including the PARTNER cardiovascular imaging publications committee and the CONFIRM-2 steering committee. He has imaged for several first-in-human structural heart device implants and has directed core lab imaging trials for several early feasibility and pivotal clinical trials. His leadership in core lab imaging has been instrumental in standardizing image interpretation across major multicenter studies, ensuring consistency in evaluating novel cardiovascular technologies.

Dr. Shin is an advanced interventional fellow at St. Francis Hospital, Roslyn, NY. He graduated with great honor from Korea University College of Medicine in Seoul, South Korea. After three years of mandatory military service in South Korea, he came to the U.S. for further clinical training and completed a cardiology fellowship at the University of Iowa and an interventional cardiology fellowship at Duke University. His research interests include intravascular imaging and coronary physiology, and he has published original papers in Circulation and JACC: Cardiovascular Interventions. Dr. Shin has also been actively involved in core lab research, contributing to the assessment of novel imaging techniques and their application in guiding complex coronary interventions. His experience in image interpretation and physiologic assessment has helped refine procedural strategies for optimizing patient outcomes.

Fernando Sosa is a seasoned healthcare executive with a proven track record of driving the adoption of innovative medical technologies. With extensive experience in the medical device industry, he has played a pivotal role in bridging the gap between groundbreaking advancements and practical clinical applications. His expertise lies in optimizing workflows, designing and executing comprehensive education programs, and implementing strategic initiatives to seamlessly integrate new technologies into healthcare systems.

Throughout his career, Fernando has successfully managed multi-million dollar medical device portfolios, spearheading upstream marketing efforts that have accelerated market adoption. His strategic approach to stakeholder engagement, research coordination, and training program development has enabled him to deliver impactful results across various healthcare settings.

In addition to his expertise in medical technology adoption, Fernando has deep experience working with core labs, where he has collaborated closely with physicians, researchers, and industry leaders to support data-driven clinical decision-making. His work in this space has involved overseeing clinical research initiatives, facilitating quality assurance processes, and ensuring that core labs operate at the highest standards to provide reliable and actionable insights. With a strong commitment to advancing patient care through innovation, Fernando continues to foster collaboration between industry, research, and clinical practice.